$3600 | Single User
$5400 | Site License
$7200 | Enterprise License

Chronic Kidney Disease - Pipeline Analysis
[Lowest Price Guaranteed: $3,600]

Published by IQ4I: 07 May 2015 | 111535 | In Stock
Related Topics: Chronic Kidney Disease (CKD) , Drug , Medical

Introduction

“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies and RNA-based therapeutics, but excludes symptom relief drugs. The report also covers some of the hot targets in research for CKD treatments.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the CKD Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CKD treatment space and potentially alter standards of care in CKD in the foreseeable future.

Current therapies are not effective and more than half of patients gradually face severe renal and cardiovascular complications, hence it provides a tremendous opportunity for upcoming therapies specific to CKD such as MAbs, stem cell-based and RNA-based therapies, which reverses disease course or slow down kidney deterioration.

Table of Contents
for Chronic Kidney Disease - Pipeline Analysis

  • REPORT DESCRIPTION

    INTRODUCTION

    • Causes & Symptoms

    • Diagnosis

    • Classification

    • Epidemiology

    HOT TARGETS, MECHANISMS AND THERAPIES

    • Associated targets

    • DNA Vaccination

    • Gene therapy

    • Tissue engineering

    MARKET DATA

    • Forecasting model

    • Market dynamics

    • Market sizing

    • Cost burden

    PIPELINE ANALYSIS

    • Development stage

    • Modalities

    • Leading players

    • Innovative approaches

    SMALL MOLECULES

    • Pipeline

    • Competitive landscape

    LARGE MOLECULES

    • Pipeline

    • Competitive landscape

    MONOCLONAL ANTIBODIES

    • Pipeline

    • Competitive landscape

    STEM CELL THERAPY

    • Pipeline

    • Competitive landscape

    RNA BASED THERAPEUTICS

    • mi-RNA

    • m-RNA

    • Pipeline

    • Competitive landscape

    MAJOR PLAYERS

    • Company Profiles

    • Overview, Pipeline & Deals

    REFERENCES

Additional Details

Publisher

IQ4I

Publisher Information

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.



We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Reference

111535 | Chronic Kidney Disease - Pipeline Analysis Report 07052015

Number of Pages

112

Report Format

PDF

IQ4I Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
The Outlook for Wearable Health Tech in Managing Chronic Disease
IntroductionWearable tech – the new golden ticket for patient adherence?Wearable technology is being...
01 May 2016 by FirstWord Pharma USD $695 More Info
Chronic Obstructive Pulmonary Disorder (COPD): Update Bulletin [Feb 2016]
IntroductionThis edition presents key opinion leader (KOL) views on recent developments in the chron...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events with the potential to shape the targeted trea...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionIn the last few years the emergence of new targeted therapies such as AbbVie’s/Janssen’s...
01 Sep 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight
IntroductionCombination therapy is set to take centre stage in the treatment of COPD as leading comp...
20 Apr 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionChronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until rece...
27 May 2014 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
IntroductionThe prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, ...
20 Jan 2014 by FirstWord Pharma USD $7,495 More Info
Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by IQ4I

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Download Free Report Summary PDF

Chronic Kidney Disease - Pipeline Analysis | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...